HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Serum hemorphin-7 levels are decreased in obesity.

AbstractOBJECTIVE:
Hemorphin peptides exhibit biological activities that interfere with the endorphin system, the inflammatory response, and blood-pressure control. VV-hemorphin-7 and LVV-hemorphin-7 peptides exert a hypotensive effect, in particular, by inhibiting the renin-angiotensin system. Furthermore, levels of circulating hemorphin-7 peptides have been found to be decreased in diseases such as type 1 and type 2 diabetes.
DESIGN AND METHODS:
Because type 2 diabetes and obesity share common features, such as insulin resistance, microinflammation, high glomerular-filtration rate (GFR), and cardiovascular risk, we evaluated serum VV-hemorphin-7 like immunoreactivity (VVH7-i.r.) levels, using an enzyme-linked immunosorbent assay method, on a group of 54 obese subjects without diabetes or hypertension, compared with a group of 33 healthy normal-weight subjects.
RESULTS:
Circulating VVH7-i.r. levels were significantly decreased in the obese group compared with the control group (1.98 ± 0.19 vs. 4.86 ± 0.54 µmol/l, respectively, P < 0.01), and a significant negative correlation between VVH7-i.r. and diastolic blood pressure (DBP) was found in obese patients (r = -0.35, P = 0.011). There was no significant correlation between VVH7-i.r. level and insulin resistance, metabolic syndrome, or GFR.
CONCLUSIONS:
The decreased serum hemorphin-7 found in obese subjects, as in diabetes, may contribute to the development of hypertension and to the cardiovascular risk associated with these metabolic diseases.
AuthorsMarie Maraninchi, Delphine Feron, Ingrid Fruitier-Arnaudin, Audrey Bégu-Le Corroller, Juan P Nogueira, Julien Mancini, René Valéro, Jean M Piot, Bernard Vialettes
JournalObesity (Silver Spring, Md.) (Obesity (Silver Spring)) Vol. 21 Issue 2 Pg. 378-81 (Feb 2013) ISSN: 1930-739X [Electronic] United States
PMID23532992 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2012 The Obesity Society.
Chemical References
  • Hemoglobins
  • Insulin
  • Peptide Fragments
  • hemorphin 7
  • LVV-hemorphin-7
  • VV-hemorphin-7
Topics
  • Adult
  • Blood Pressure
  • Body Mass Index
  • Case-Control Studies
  • Diabetes Mellitus, Type 2 (blood, complications)
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Glomerular Filtration Rate
  • Hemoglobins
  • Humans
  • Hypertension (blood, complications)
  • Insulin (blood)
  • Insulin Resistance
  • Male
  • Metabolic Syndrome X (blood, complications)
  • Middle Aged
  • Obesity (blood, complications)
  • Peptide Fragments (blood)
  • Renin-Angiotensin System
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: